| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |